Peginterferon-??-2a (40kD) Plus Ribavirin

This publication has 26 references indexed in Scilit:

• Ribavirin inhibits DNA, RNA, and protein synthesis in PHA‐stimulated human peripheral blood mononuclear cells: Possible explanation for therapeutic efficacy in patients with chronic HCV infection
  Journal of Medical Virology, 2002
• The single dose pharmacokinetics of ribavirin in subjects with chronic liver disease
  British Journal of Clinical Pharmacology, 2000
• EASL International Consensus Conference on Hepatitis C Paris, 26–28 February 1999
  Journal of Hepatology, 1999
• Tolerance and efficacy of oral ribavirin treatment of chronic hepatitis C: A multicenter trial
  Hepatology, 1997
• Ribavirin treatment for patients with chronic hepatitis C: results of a placebo-controlled study
  Journal of Hepatology, 1996
• Influence of human immunodeficiency virus type 1 infection on the natural course of chronic parenterally acquired Hepatitis C
  European Journal of Clinical Microbiology & Infectious Diseases, 1995
• Major Therapeutic Uses of Interferons
  Clinical Immunotherapeutics, 1995
• Hepatitis C viral RNA titers in serum prior to, during, and after oral treatment with ribavirin for chronic hepatitis C
  Journal of Medical Virology, 1993
• A Pilot Study of Ribavirin Therapy for Chronic Hepatitis C
  Hepatology, 1992
• Ribavirin treatment for chronic hepatitis C
  The Lancet, 1991